Novartis opens cell and gene therapy facility ahead of time
The Swiss manufacturing facility will be responsible for the manufacture of cell and gene therapies, including Kymriah.
Archives for December 3, 2019
Entera tips contract manufacturing investments to give it an edge
Entera Bio tips investments in manufacturing to give it an edge by driving down the cost of making its products.
‘Insatiable’ demand drives up expectations for Catalent's gene therapy unit
Analyst increases estimate of revenue potential of Catalent’s gene therapy unit in light of ‘insatiable’ demand.